Overview: Hepatitis G RNA PCR TestIntroduction: The Hepatitis G RNA PCR Test detects hepatitis G viral RNA to diagnose infection, potentially causing liver issues. Aligned with 2023 AASLD guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, assessing clinical relevance, and improving outcomes in virology for patients with suspected hepatitis G (HGV), though its clinical significance remains debated.
Other Names: HGV PCR Assay, Hepatitis G Detection Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: Hepatitis G (HGV) was identified in the 1990s. PCR-based RNA detection assays were developed in the 2000s, enhancing diagnostic capabilities despite unclear clinical impact.
Purpose: Diagnoses hepatitis G infection, assesses clinical relevance, and detects HGV RNA in patients with potential liver issues.
Test Parameters: 1. Hepatitis G Virus RNA
Pretest Condition: No fasting required. Collect serum, plasma, or saliva at any time. Report symptoms like fatigue or liver pain, and list medications or risk factors (e.g., blood transfusions).
Specimen: 2-5 mL serum (SST), 2-4 mL plasma (EDTA), or 1-2 mL saliva (sterile container). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, liver pain, or history of blood transfusions or hepatitis exposure. Include current medications and co-infections (e.g., HCV, HBV).
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for further evaluation due to unclear clinical significance.
Procedural Considerations: Uses PCR to detect HGV RNA. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often in research or co-infection settings.
Factors Affecting Result Accuracy: Improper sample handling, contamination, or low viral load can affect results. Co-infections (e.g., HCV) may complicate interpretation.
Clinical Significance: Positive HGV RNA confirms infection, but clinical relevance is unclear, as HGV rarely causes significant liver disease. Co-infections may require further evaluation.
Specialist Consultation: Consult a hepatologist for result interpretation and management planning, especially in co-infection cases.
Additional Supporting Tests: Anti-HCV, HBV markers, or liver function tests to assess co-infections and liver health.
Test Limitations: Unclear clinical significance of HGV. False negatives may occur in low viral load. Clinical correlation is essential.
References: AASLD Hepatitis Guidelines, 2023; Hepatology, Alter MJ, 2022.
